Medication info
Eshuba Tablets 10/5 mg (Ezetimibe, Rosuvastatin)

Eshuba Tablets 10/5 mg (Ezetimibe, Rosuvastatin)

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletRosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets (10 tablets PTP x 3), 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201601201 · Approved 2016.02.29 · Insurance code 670607440

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended starting dose is 10/5mg once daily. For patients who require a greater reduction in LDL cholesterol, the dose may be adjusted. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose should be adjusted accordingly; it may be increased up to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • increased LDL cholesterol
  • increased apolipoprotein B
  • increased triglycerides
  • increased non-HDL cholesterol
  • decreased HDL cholesterol
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia.
View approved original text

This medication helps lower total cholesterol, LDL-cholesterol, apolipoprotein B, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing HDL cholesterol levels, known as good cholesterol. It is primarily used as an adjunct to diet, effective when used alongside proper dietary modifications, including restrictions on saturated fat and cholesterol. When prescribing lipid-lowering medications to patients at high risk for atherosclerotic vascular disease, various risk factors should be considered, and it is important to first identify and treat secondary causes of dyslipidemia. Additionally, regular testing is necessary to accurately assess blood lipid levels, and in special cases, ultracentrifugation may be used to measure LDL cholesterol concentrations. This medication is effectively used for the treatment of hypercholesterolemia by assisting in the management of healthy blood lipid levels.

How to take

Adult dose

This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended starting dose is 10/5mg once daily. For patients who require a greater reduction in LDL cholesterol, the dose may be adjusted. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose should be adjusted accordingly; it may be increased up to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication carries a risk of muscle-related side effects; therefore, if severe muscle pain or weakness occurs, the doctor should be notified immediately. Especially in patients with serious infections, hypotension, significant surgery or trauma, severe metabolic or endocrine disorders, uncontrolled seizures, it may be necessary to temporarily discontinue or stop this medication. Patients allergic to any of the components of this medication, those with active liver disease, muscle disorders, severe kidney function impairment, women who are pregnant or breastfeeding should not take this medication. Additionally, caution is advised for those with a history or family history of certain muscle disorders, hypothyroidism, alcoholism, or those taking specific medications. This medication contains lactose; therefore, patients with genetic predispositions to lactose intolerance should avoid taking it. Patients with poor liver function or a history of alcoholism, the elderly, and those with impaired kidney function should use this medication cautiously. This medication may increase liver enzyme levels; therefore, liver function tests should be conducted before initiation, and regular monitoring of liver condition should continue during treatment. If any unusual liver symptoms or jaundice occur during treatment, administration should be stopped immediately. This medication may slightly raise blood sugar levels; hence, patients at risk for diabetes should regularly monitor their blood sugar. There may be interactions with other drugs; therefore, patients taking other medications should inform their doctor or pharmacist. Caution is particularly necessary when taken with anticoagulants, fibrates, certain antibiotics, and antifungals. This medication should not be taken by women who are pregnant or may become pregnant, and appropriate contraception should be used while taking it. It is also advised that breastfeeding women avoid this medication. Safety for children and adolescents has not been sufficiently established; therefore, it is not recommended. In cases of overdose, no specific antidote exists, and symptomatic treatment and supportive care are necessary while monitoring liver function and muscle status. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, ALT elevation, AST elevation, ALP elevation, abnormal liver function tests, dizziness, chest pain, fatigue, myalgia, rash, nasopharyngitis, angioedema, diabetes, headache, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, myositis, weakness, thrombocytopenia, jaundice, hepatitis, toxic hepatitis, acute hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased blood alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, sweating, dermatitis, burning sensation of the skin, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid drooping, diabetic retinopathy, ear discomfort, kidney dysfunction, benign esophageal neoplasm, chest pain, facial swelling, strange sensations, drug intolerance, irritable bowel syndrome, esophagitis, somnolence, neurodegenerative disorders, positional dizziness, migraine, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hematuria, edema, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, urticaria, hyperhidrosis, pruritus, upper respiratory infection, conjunctival congestion, renal failure, abnormal liver function, increased serum creatinine, hypertension, increased blood urea, increased CPK, abnormal liver function tests, numbness, sensory disturbances, chest discomfort, loss of appetite, abdominal distension, syncope, systemic pain, muscle cramps, gout, erectile dysfunction, myalgia, joint pain, acute renal failure, oliguria, thrombocytopenia, increased serum creatinine, myalgia, myopathy, rhabdomyolysis, immune-mediated necrotizing myopathy, liver failure, severe muscle weakness, ocular myasthenia, interstitial lung disease, sexual dysfunction, gynecomastia, cognitive impairment, depression, sleep disturbances, insomnia, nightmares

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is recommended to keep it at room temperature between 1 to 30 degrees Celsius, avoiding extreme heat or cold.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets (10 tablets PTP x 3), 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.